New California law bans loud ads on streaming services for ‘peace and quiet’

California's new AI law, championed by Governor Gavin Newsom, has made significant changes by removing the controversial 'kill switch' while implementing essential guardrails for users and companies. This legislation is crucial as it aims to foster innovation in artificial intelligence while ensuring safety and accountability, striking a balance that could serve as a model for other states.

California's new AI law, championed by Governor Gavin Newsom, has made significant changes by removing the controversial 'kill switch' while implementing essential guardrails for users and companies. This legislation is crucial as it aims to foster innovation in artificial intelligence while ensuring safety and accountability, striking a balance that could serve as a model for other states.

California's new AI law, championed by Governor Gavin Newsom, has made significant changes by removing the controversial 'kill switch' while implementing essential guardrails for users and companies. This legislation is crucial as it aims to foster innovation in artificial intelligence while ensuring safety and accountability, striking a balance that could serve as a model for other states.

Fans of the 'Monster' anthology series can rejoice as the release of 'Monster: The Ed Gein Story' starring Charlie Hunnam has sparked excitement about a potential fourth season. With the show's unique storytelling and captivating performances, viewers are eager to see what Netflix will bring next. The anticipation surrounding the series highlights its popularity and the audience's desire for more thrilling narratives.

Fans of the 'Monster' anthology series can rejoice as the release of 'Monster: The Ed Gein Story' starring Charlie Hunnam has sparked excitement about a potential fourth season. With the show's unique storytelling and captivating performances, viewers are eager to see what Netflix will bring next. The anticipation surrounding the series highlights its popularity and the audience's desire for more thrilling narratives.

Fans of the 'Monster' anthology series can rejoice as the release of 'Monster: The Ed Gein Story' starring Charlie Hunnam has sparked excitement about a potential fourth season. With the show's unique storytelling and captivating performances, viewers are eager to see what Netflix will bring next. The anticipation surrounding the series highlights its popularity and the audience's desire for more thrilling narratives.

California Governor Gavin Newsom has signed a significant bill aimed at limiting the influence of private equity firms in the healthcare sector. This new law empowers the state to take action against buyout firms that meddle in healthcare decisions at the medical practices they own. This is a crucial step towards ensuring that patient care remains the priority, rather than profit motives, and it highlights California's commitment to protecting healthcare integrity.

California Governor Gavin Newsom has signed a significant bill aimed at limiting the influence of private equity firms in the healthcare sector. This new law empowers the state to take action against buyout firms that meddle in healthcare decisions at the medical practices they own. This is a crucial step towards ensuring that patient care remains the priority, rather than profit motives, and it highlights California's commitment to protecting healthcare integrity.

California Governor Gavin Newsom has signed a significant bill aimed at limiting the influence of private equity firms in the healthcare sector. This new law empowers the state to take action against buyout firms that meddle in healthcare decisions at the medical practices they own. This is a crucial step towards ensuring that patient care remains the priority, rather than profit motives, and it highlights California's commitment to protecting healthcare integrity.

This weekend brings an exciting lineup of new content across popular streaming platforms like Netflix, Hulu, and Prime Video. With a variety of shows and movies to choose from, viewers can look forward to fresh entertainment options that cater to all tastes. This is significant as it highlights the ongoing competition among streaming services to attract and retain subscribers, ensuring that audiences have plenty of choices for their viewing pleasure.

This weekend brings an exciting lineup of new content across popular streaming platforms like Netflix, Hulu, and Prime Video. With a variety of shows and movies to choose from, viewers can look forward to fresh entertainment options that cater to all tastes. This is significant as it highlights the ongoing competition among streaming services to attract and retain subscribers, ensuring that audiences have plenty of choices for their viewing pleasure.

This weekend brings an exciting lineup of new content across popular streaming platforms like Netflix, Hulu, and Prime Video. With a variety of shows and movies to choose from, viewers can look forward to fresh entertainment options that cater to all tastes. This is significant as it highlights the ongoing competition among streaming services to attract and retain subscribers, ensuring that audiences have plenty of choices for their viewing pleasure.

Mizuho has lowered its stock price target for Shift4 Payments due to international headwinds affecting the company's performance. This adjustment reflects concerns about the challenges Shift4 may face in global markets, which could impact its growth and profitability. Investors should pay attention to these developments as they could influence the stock's future trajectory.

RBC Capital has raised its price target for Select Medical's stock to $20, citing recent regulatory relief as a key factor. This adjustment reflects growing confidence in the company's future performance and highlights the positive impact of regulatory changes on its operations. Investors may see this as a promising sign for Select Medical's growth potential.

Mizuho has lowered its price target for Corteva's stock to $78 following the company's announcement of a stock split. This adjustment reflects concerns about the potential impact of the split on investor confidence and market performance. Investors should pay attention to how this change might affect Corteva's stock in the coming months, as it could influence trading strategies and overall market sentiment.

Zenas Biopharma has successfully licensed three promising autoimmune candidates from InnoCare, marking a significant step forward in their development pipeline. This collaboration not only enhances Zenas's portfolio but also underscores the growing importance of innovative treatments in the autoimmune space. The partnership is expected to accelerate research and bring new therapies to patients in need, highlighting the potential for improved health outcomes.

Frontline stock has received a reaffirmed 'Buy' rating from BTIG, reflecting confidence in the company's performance amid a robust tanker market. This endorsement is significant as it highlights the potential for growth and profitability in the shipping sector, which is currently benefiting from increased demand and favorable market conditions.

In a remarkable achievement, Yoshio Kitagawa, David Robson, and Omar Yaghi have been awarded the 2025 Nobel Prize in Chemistry for their groundbreaking work in the field of porous materials. This recognition not only highlights their innovative contributions but also underscores the importance of chemistry in addressing global challenges such as energy storage and environmental sustainability. Their research paves the way for future advancements that could significantly impact various industries and improve our daily lives.